Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Harvard Business School
Boehringer Ingelheim
Medtronic
Dow
AstraZeneca
McKinsey

Last Updated: August 15, 2022

Investigational Drug Information for Tauroursodeoxycholic acid


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What is the development status for investigational drug Tauroursodeoxycholic acid?

Tauroursodeoxycholic acid is an investigational drug.

There have been 22 clinical trials for Tauroursodeoxycholic acid. The most recent clinical trial was a Phase 3 trial, which was initiated on December 1st 2012.

The most common disease conditions in clinical trials are Sclerosis, Motor Neuron Disease, and Amyotrophic Lateral Sclerosis. The leading clinical trial sponsors are Washington University School of Medicine, Amylyx Pharmaceuticals Inc., and IRCCS Policlinico S. Matteo.

There are three hundred and forty US patents protecting this investigational drug and two international patents.

Recent Clinical Trials for Tauroursodeoxycholic acid
TitleSponsorPhase
The Clinical Application of Tauroursodeoxycholic Acid in Patients With Liver Fibrosis.The First Affiliated Hospital with Nanjing Medical UniversityEarly Phase 1
Targeting ER Stress in Vascular DysfunctionColorado State UniversityEarly Phase 1
Safety and Efficacy of TUDCA as add-on Treatment in Patients Affected by ALSBruschettini S.r.l.Phase 3

See all Tauroursodeoxycholic acid clinical trials

Clinical Trial Summary for Tauroursodeoxycholic acid

Top disease conditions for Tauroursodeoxycholic acid
Top clinical trial sponsors for Tauroursodeoxycholic acid

See all Tauroursodeoxycholic acid clinical trials

US Patents for Tauroursodeoxycholic acid

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Tauroursodeoxycholic acid See Plans and Pricing Measurement method for human pancreatic lipase activity ASAHI KASEI PHARMA CORPORATION (Tokyo, JP) See Plans and Pricing
Tauroursodeoxycholic acid See Plans and Pricing 17-hydroxyprogesterone ester-containing oral compositions and related methods Lipocine Inc. (Salt Lake City, UT) See Plans and Pricing
Tauroursodeoxycholic acid See Plans and Pricing Orally disintegrating dosage form for administration of avanafil, and associated methods of manufacture and use Vivus, Inc. (Campbell, CA) See Plans and Pricing
Tauroursodeoxycholic acid See Plans and Pricing Animal model of nash-induced hepatocellular carcinoma and methods for developing specific therapeutics The Regents of the University of California (Oakland, CA) See Plans and Pricing
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Tauroursodeoxycholic acid

Drugname Country Document Number Estimated Expiration Related US Patent
Tauroursodeoxycholic acid China CN105164273 2033-04-18 See Plans and Pricing
Tauroursodeoxycholic acid European Patent Office EP2987867 2033-04-18 See Plans and Pricing
Tauroursodeoxycholic acid Spain ES2654437 2033-04-18 See Plans and Pricing
Tauroursodeoxycholic acid Japan JP6064041 2033-04-18 See Plans and Pricing
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Boehringer Ingelheim
Medtronic
Dow
AstraZeneca
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.